Reduction of Dentine Hypersensitivity After Use of Different Dentifrices

Armed Forces Institute of Dentistry, Pakistan87 enrolled

Overview

To assess the impact of the use of 5% Calcium Sodium Phosphosilicate or 8% Arginine dentifrices on dentinal hypersensitivity following non-surgical periodontal therapy in patients with periodontitis.

To assess the impact of the use of 5% Calcium Sodium Phosphosilicate or 8% Arginine dentifrices on dentinal hypersensitivity following non-surgical periodontal therapy in patients with periodontitis. patients will be selected on the bases of inclusion and exclusion criteria.Descriptive statistics will be presented for both qualitative and quantitative variables

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

QUADRUPLE

Enrollment

Conditions

Sensitivity, Tooth

Interventions

5% CALCIUM SODIUM PHOSPHOSILICATEDRUG

Calcium sodium phosphosilicate is a particulate, bioactive glass material that degrades in the aqueous oral environment to release calcium and phosphate ions, leading to formation of hydroxycarbonate apatite on the dentine surface result in reduction in dentine hypersenstivity

8% ArginineDRUG

Arginine contributes to Whole Mouth Health. It also plays a role with respect to dental caries, helping to maintain a pH-neutral environment, and is proven to rapidly help relieve dentin sensitivity. Arginine is truly a remarkable ingredient now being used in oral care products.

Eligibility

Sex: ALLMin age: 30 YearsMax age: 65 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: 1. Participants must be between 30 and 65 years old. 2. Participants should be in good general health. 3. Participants must have a diagnosis of generalized chronic periodontitis according to the 1999 classification definition. 4. Participants should complain of at least two teeth with dentinal hypersensitivity. 5. Participants must exhibit moderate to severe dentinal hypersensitivity (Schiff's scores of 2 to 3) or tactile stimulation (Visual Analogue Scale (VAS) score \>4) after at least one scaling and root planing session. Exclusion Criteria: 1. Individuals with dentinal hypersensitivity symptoms prior to periodontal treatment. 2. Those who have used agents to treat hypersensitivity in the past 3 months. 3. Participants who are allergic to the test products (5% CSPS or 8% arginine). 4. Dentinal hypersensitivity caused by factors such as dental caries, defective restorations, fractured teeth, abrasion or abfraction, extensively restored teeth, or restorations extending into the test area. 5. Individuals who have undergone orthodontic treatment within the past 3 months. 6. Patients with crowded teeth or serving as abutment teeth for fixed or removable prostheses are also excluded from the study.

Locations (1)

AFID

Rawalpindi, Pakistan

RECRUITING

Outcomes

Primary Outcomes

To assess the impact on Dentinal hypersensitivity following the use of 5% CSPS or 8% Arginine following non-surgical periodontal therapy in patients with Periodontitis by VAS.

Define pain and discomfort via running a probe on dentine of tooth The most simple VAS is a straight horizontal line of fixed length, usually 100 mm. The ends are defined as the extreme limits of the parameter to be measured (symptom, pain, health) orientated from the left (worst) to the right (best). In some studies, horizontal scales are orientated from right to left.

Time frame: within 8 weeks from the start of procedure

To assess the impact on Dentinal hypersensitivity following the use of 5% CSPS or 8% Arginine following non-surgical periodontal therapy in patients with Periodontitis by Schiff scale.

Schiff Cold Air Sensitivity Scale: is a tool used to assess dentinal hypersensitivity (DH) or tooth sensitivity to cold air. It's a clinical method developed to quantify the severity of cold air sensitivity experienced by individuals with dentin hypersensitivity. The scale typically ranges from 0 to 3, with the following descriptions: 0: No response to cold air 1. Mild, brief, or localized response to cold air 2. Moderate response to cold air, patient can tolerate 3. Severe and prolonged response to cold air, patient finds it intolerable

Time frame: within 8 weeks from the start of procedure

Central Contacts

Muhammad J Iqbal, BDS

CONTACT

03432656612 dr.muhammadjunaid@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.